Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4630628 | 0.91 | EDNRA (0.76) | EDNRAEDNRB | |
| SCHEMBL9063031 | 0.91 | EDNRA (0.76) | EDNRAEDNRB | |
| SCHEMBL6962503 | 0.89 | EDNRA (0.73) | EDNRAEDNRB | |
| SCHEMBL7344575 | 0.89 | EDNRA (0.73) | EDNRAEDNRB | |
| SCHEMBL4631538 | 0.89 | EDNRA (0.83) | EDNRAEDNRB | |
| SCHEMBL6150975 | 0.86 | EDNRA (1.00) | EDNRAEDNRB | |
| SCHEMBL6151190 | 0.85 | EDNRA (0.76) | EDNRAEDNRB | |
| SCHEMBL6954823 | 0.85 | EDNRA (0.76) | EDNRAEDNRB | |
| SCHEMBL6151652 | 0.84 | EDNRA (0.78) | EDNRAEDNRB | |
| SCHEMBL6152785 | 0.84 | EDNRA (0.74) | EDNRAEDNRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1636994-B | Process of preparing alkali metal salys of hydrophobic sulfonamides and alkali metal salt produced thereby | ENCYSIVE PHARMACEUTICALS INC | 2010-05-12 | — | — | CN | disclosed |
| CN-1636994-A | Process of preparing alkali metal salys of hydrophobic sulfonamides and alkali metal salt produced thereby | ENCYSIVE PHARMACEUTICALS INC (US) | 2005-07-13 | — | — | CN | disclosed |
| CN-1179961-C | Sulfonamides for the treatment of endothelin mediated diseases | ��ɪϣ����ҩ��˾ | 2004-12-15 | — | — | CN | disclosed |
| CN-1253560-A | Sulfonamides for the treatment of endothelin mediated diseases | TEXA BIOTECHNOLOGY CORP (US) | 2000-05-17 | — | — | CN | disclosed |